About PrecisionLife | Precision medicine for complex, chronic diseases

Skip to content

Our mission

Finding better, more personalized treatment & diagnostic options for people with unmet medical needs

Complex, chronic diseases are difficult to diagnose, expensive to manage, and often lack effective treatments. They represent the biggest challenge to health – affecting billions of patients and accounting for over 80% of global healthcare spending.

New proactive and preventative healthcare approaches are required to accurately identify people who are at-risk and intervene effectively to reduce the global burden of chronic diseases.

We bring the benefits of precision medicine affordably into routine clinical practice and R&D for these most common and costly diseases.

Predicting, preventing, diagnosing & treating disease to improve patient outcomes.

This is PrecisionLife.

A snapshot of our progress

Linking patients to effective treatments by the mechanism of their disease

Improving global health

>5 Billion patients lives

PrecisionLife disease studies create precision medicine opportunities in diseases with a prevalence of 5.4B people.

Proprietary disease insights

100K+ protectable trade secrets

We've created the world's largest repository of chronic disease insights & IP, including biomarkers, risk models, and novel targets.

World-leading science

10x signal from 10% of the data

Our platform has identified previously unknown causal biology - the holy grail of precision medicine - in over 60 diseases.

Rapid reduction to practice

Reducing the cost of healthcare

Our mechanostic tests identify disease risk for earlier, more personalized intervention and prevention of chronic diseases.

2.ALZHEIMERS-min

A new era of precision medicine

Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.

These differences cannot be understood by traditional genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.

Therefore, while oncology has been transformed by precision medicine, more prevalent and expensive chronic diseases have not.

Until now...

Putting people at the center of their health

We've completely reimagined how to analyze patient data.

Using our Combinatorial Analytics & AI platform we are the first company to understand and stratify complex disease biology – identifying the mechanistic causes of disease in individual patients.

This allows us to create more personalized diagnostic tools, therapy options and clinical pathways, and to find the right patients for new trials and treatments based on their personal biology.

Increasing success for clinical trials, treatments and patients.

Patients at center of their health (2)-min (1)